A biocompatible hydrogel
containing a hexapeptide as a key unit
has been designed and fabricated. Our design construct comprises a
β-sheet-rich short hexapeptide in the center with a hydrophobic
long chain and hydrophilic triple lysine unit attached at the N- and
C-terminals, respectively. Thus, it is this amphiphilic nature of
the molecule that facilitates gelation. It can capture solvent molecules
in the three-dimensional cross-linked fibrillar networks. The amphiphilic
character of the construct has been modulated to produce an excellent
biocompatible soft material for the inhibition of bacterial growth
by rupturing the bacterial cell membrane. This hydrogel is also stable
against enzymatic degradation (proteinase K) and, most importantly,
offers a biocompatible environment for the growth of normal mammalian
cells due to its noncytotoxic nature as observed through the cell
viability assay. From the hemolytic assay, the morphology of the human
red blood cells is found to be almost intact, which suggests that
the hydrogel can be used in biomedical applications. Thus, this newly
designed antibacterial hydrogel can be used as both an antibacterial
biomaterial and a biocompatible scaffold for mammalian cell culture.